ClinicalTrials.Veeva

Menu

ITA Vs LAD; Evaluation of Inflammatory Burden in OP-CABG Patients

C

Cardiochirurgia E.H.

Status

Completed

Conditions

Coronary Artery Disease
Ischemic Heart Disease
Inflammation
Atherosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT05574621
EH2021-01

Details and patient eligibility

About

Introduction. Ischemic cardiomyopathy is one of the death leading causes in industrialized countries. Up-to-date ESC guidelines recommend a surgical approach (coronary by pass graft) in patients with multivessel coronaropathy, with involvement of left main (LM) or proximal left anterior descending (LAD) artery. In any case, is recommended the use of the internal thoracic artery (ITA) as conduct of choice.

In consideration of the very strong evidence supporting the use of ITA, the study objective is to analyze and compare some blood markers collected from ITA blood vs. LAD blood, with the purpose of better understanding the technique benefits from a biological point of view, being the hemodynamic one already evident.

Methods. Forty patients scheduled for coronary bypass graft (CABG) surgery at the Cardiac Surgery Unit of European Hospital of Rome will be enrolled. Patients which intervention includes off-pump ITA-LAD anastomosis will be included. For each patient blood sample from ITA and LAD will be collected. On those samples, polymorphonuclear leukocytes and platelets activity, endothelial dysfunction, oxidative stress and inflammatory burden will be analysed. In patients in which a pre-operative coronary CT scan is available, findings will be correlated with atherosclerotic plaque morphology.

Expected results. Diseased LAD's blood will have a deranged markers profile compared with ITA's, with augmented inflammatory burden, reduce NO availability and increased platelet activation. In the patients subgroup with available coronary CT scan will be possible to esteem the effective blood mixing and speculate on a possible pharmacological effect of CABG, in terms of dilution of inflammatory burden in the target vessel.

Enrollment

20 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled coronary bypass surgery
  • Off-pump procedure
  • ITA-LAD anastomosis

Exclusion criteria

  • STEMI in the last month
  • LVEF > 30%
  • LAD chronic occlusion
  • Acute or chronic inflammatory diseases
  • Immunologic or rheumatic diseases
  • Oncologic condition (present or in the last 3 years)
  • Active infections

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems